ATE61347T1 - Zytoprotektive derivate zur anwendung bei ischaemischen erkrankungen, ihre herstellung und sie enthaltende zusammensetzungen. - Google Patents
Zytoprotektive derivate zur anwendung bei ischaemischen erkrankungen, ihre herstellung und sie enthaltende zusammensetzungen.Info
- Publication number
- ATE61347T1 ATE61347T1 AT86117895T AT86117895T ATE61347T1 AT E61347 T1 ATE61347 T1 AT E61347T1 AT 86117895 T AT86117895 T AT 86117895T AT 86117895 T AT86117895 T AT 86117895T AT E61347 T1 ATE61347 T1 AT E61347T1
- Authority
- AT
- Austria
- Prior art keywords
- methyl
- hydrogen
- cytoprotective
- group
- formula
- Prior art date
Links
- 230000001120 cytoprotective effect Effects 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000000302 ischemic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 abstract 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001409 amidines Chemical class 0.000 abstract 1
- 230000002253 anti-ischaemic effect Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229940045200 cardioprotective agent Drugs 0.000 abstract 1
- 239000012659 cardioprotective agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000002636 imidazolinyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23373/85A IT1201511B (it) | 1985-12-23 | 1985-12-23 | Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono |
| EP86117895A EP0230037B1 (de) | 1985-12-23 | 1986-12-22 | Zytoprotektive Derivate zur Anwendung bei ischämischen Erkrankungen, ihre Herstellung und sie enthaltende Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE61347T1 true ATE61347T1 (de) | 1991-03-15 |
Family
ID=11206518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86117895T ATE61347T1 (de) | 1985-12-23 | 1986-12-22 | Zytoprotektive derivate zur anwendung bei ischaemischen erkrankungen, ihre herstellung und sie enthaltende zusammensetzungen. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4789681A (de) |
| EP (1) | EP0230037B1 (de) |
| JP (1) | JPS62158249A (de) |
| AT (1) | ATE61347T1 (de) |
| CA (1) | CA1284646C (de) |
| DE (1) | DE3677943D1 (de) |
| ES (1) | ES2020508B3 (de) |
| GR (1) | GR3001879T3 (de) |
| IT (1) | IT1201511B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028627A (en) * | 1989-09-13 | 1991-07-02 | Cornell Research Foundation, Inc. | Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| US5770623A (en) * | 1989-09-13 | 1998-06-23 | Board Of Regents, The University Of Texas System | Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| GB8929076D0 (en) * | 1989-12-22 | 1990-02-28 | Scras | Treatment of shock by blocking agents of edrf effect or formation |
| US5318992A (en) * | 1990-02-26 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of nitric oxide biosynthesis |
| CA2036770C (en) * | 1990-02-26 | 2003-09-09 | Jeffrey P. Whitten | Inhibitors of nitric oxide biosynthesis |
| US5710324A (en) * | 1990-02-26 | 1998-01-20 | Merrell Pharmaceuticals Inc. | Inhibitors of nitric oxide biosynthesis |
| US5585402A (en) * | 1992-12-23 | 1996-12-17 | Glaxo Wellcome Inc. | Nitric oxide synthase inhibitors |
| AU6950294A (en) * | 1993-05-14 | 1994-12-12 | Amira, Inc. | Treating body parts susceptible to ischemia using creatine analogs |
| GB9312761D0 (en) * | 1993-06-21 | 1993-08-04 | Wellcome Found | Amino acid derivatives |
| DE793646T1 (de) | 1994-11-23 | 1999-12-30 | Pharmacia & Upjohn Co., Kalamazoo | Carboxylierte aminoguanidine zum behandlung von insulin-unabhängigem diabetes mellitus |
| WO1996018607A1 (en) * | 1994-12-12 | 1996-06-20 | Chugai Seiyaku Kabushiki Kaisha | Aniline derivative having the effect of inhibiting nitrogen monoxide synthase |
| DE19544686A1 (de) * | 1995-11-30 | 1997-06-05 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE19544685A1 (de) * | 1995-11-30 | 1997-06-05 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5955617A (en) * | 1996-05-21 | 1999-09-21 | Pharmacia & Upjohn Company | Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus |
| WO2000010546A2 (en) * | 1998-08-25 | 2000-03-02 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | D-arginine for the treatment of neorodegenerative diseases |
| CA2587444C (en) * | 2004-11-12 | 2013-09-10 | Ucl Business Plc | Guanidine derivatives as inhibitors of ddah |
| CN109593052B (zh) * | 2018-11-20 | 2021-04-20 | 首都医科大学 | 用于诊断和治疗的放射性精氨酸衍生物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1195303B (de) * | 1964-04-16 | 1965-06-24 | Bayer Ag | Verfahren zur Herstellung von tetracyclischen und pentacyclischen Triterpenamidino-hydrazonen |
| US3576844A (en) * | 1966-10-13 | 1971-04-27 | Sumitomo Chemical Co | N-alkoxycarbonyl-aminoalkyl guanidines |
| FR2390954A1 (fr) * | 1976-10-13 | 1978-12-15 | Choay Sa | Nouvelles guanylhydrazones, leurs procedes de preparation et medicaments les contenant |
| IT1127322B (it) * | 1979-12-28 | 1986-05-21 | Italfarmaco Spa | Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici |
| IT1127321B (it) * | 1979-12-28 | 1986-05-21 | Italfarmaco Spa | Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi |
| US4499068A (en) * | 1982-08-26 | 1985-02-12 | Johnson & Johnson Products, Inc. | Oral compositions comprising NG -alkyl derivatives of arginine |
| US4477429A (en) * | 1982-08-26 | 1984-10-16 | Johnson & Johnson Products, Inc. | Oral compositions comprising N.sup.α -alkyl derivatives of arginine |
-
1985
- 1985-12-23 IT IT23373/85A patent/IT1201511B/it active
-
1986
- 1986-12-22 AT AT86117895T patent/ATE61347T1/de not_active IP Right Cessation
- 1986-12-22 JP JP61306184A patent/JPS62158249A/ja active Pending
- 1986-12-22 US US06/944,949 patent/US4789681A/en not_active Expired - Fee Related
- 1986-12-22 DE DE8686117895T patent/DE3677943D1/de not_active Expired - Lifetime
- 1986-12-22 ES ES86117895T patent/ES2020508B3/es not_active Expired - Lifetime
- 1986-12-22 EP EP86117895A patent/EP0230037B1/de not_active Expired - Lifetime
- 1986-12-23 CA CA000526235A patent/CA1284646C/en not_active Expired - Lifetime
-
1991
- 1991-04-29 GR GR91400552T patent/GR3001879T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1201511B (it) | 1989-02-02 |
| EP0230037A1 (de) | 1987-07-29 |
| GR3001879T3 (en) | 1992-11-23 |
| US4789681A (en) | 1988-12-06 |
| ES2020508B3 (es) | 1991-08-16 |
| JPS62158249A (ja) | 1987-07-14 |
| DE3677943D1 (de) | 1991-04-11 |
| CA1284646C (en) | 1991-06-04 |
| EP0230037B1 (de) | 1991-03-06 |
| IT8523373A0 (it) | 1985-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE61347T1 (de) | Zytoprotektive derivate zur anwendung bei ischaemischen erkrankungen, ihre herstellung und sie enthaltende zusammensetzungen. | |
| ATE175958T1 (de) | Farnesyl-transferase-inhibitoren, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE3781716D1 (de) | Mittel zur ortsspezifischen alkylierung. | |
| NO165145C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater. | |
| ATE117681T1 (de) | Chinolinderivate, ihre herstellung und verwendung. | |
| KR860005794A (ko) | 이미다졸 유도체의 제조방법 | |
| ATE109770T1 (de) | Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten. | |
| ES2065994T3 (es) | Beta-dicetonas substituidas. | |
| ES8504722A1 (es) | Un metodo de preparar derivados de 4-quinolona | |
| ATE1598T1 (de) | 5(10- 9)abeo-ergolin-derivate, ihre herstellung und sie enthaltende therapeutische zusammensetzungen. | |
| BG102429A (en) | Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means | |
| ES2067601T3 (es) | Derivados de arilpirazoles como inhibidores de la agregacion de plaquetas. | |
| ES2058182T3 (es) | Analogos de mitomicina. un procedimiento para su preparacion y composiciones farmaceuticas. | |
| KR860004040A (ko) | 3,4-디아졸 유도체의 제조방법 | |
| FR2633622B1 (fr) | Derives de sulfonyl indolizine, leur procede de preparation et leur utilisation comme intermediaires de synthese | |
| IT1205114B (it) | 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
| ATE46158T1 (de) | 1,3-dithiolderivate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |